SeekingAlpha  7 hrs ago  Comment 
Motley Fool  8 hrs ago  Comment 
There's more to the deals than the big headline numbers.
Motley Fool  9 hrs ago  Comment 
Even a secondary offering didn't dampen enthusiasm for the company's new lead candidate.
Benzinga  9 hrs ago  Comment 
Catalent, Inc. (NYSE: CTLT)’s plans for expansion of its biologics segment are likely to bring the stock back after weak second-quarter comps and reaccelerate growth through 2019, according to Raymond James. The Analyst Michael Baker of...
Benzinga  Mar 21  Comment 
A number of biotech stocks are poised to make big moves Wednesday. Here's the news behind these moves. Prothena Strikes It Rich With Celgene Prothena Corporation PLC (NASDAQ: PRTA) was up 19 percent after the late-stage clinical biotech...
GenEng News  Mar 21  Comment 
Celgene will partner with Prothena to develop new treatments for neurodegenerative disorders. Including Alzheimer’s disease, through a collaboration that Prothena said could generate for it up to $150 million-plus—but which could yield more...
FierceBiotech  Mar 21  Comment 
Proteostasis Therapeutics has canned plans to sell shares after seeing its stock drop 26% in the wake of a short attack. The biotech unveiled plans to sell 9 million shares hours before Kerrisdale Capital’s attack and abandoned them hours after...
Motley Fool  Mar 21  Comment 
The potential to leap from clinical-stage to commercial-stage biotech makes this my top pick right now.
FierceBiotech  Mar 21  Comment 
Alder BioPharmaceuticals has parted company with its CEO. The decision, which Alder described as mutual, leaves the biotech without a permanent leader in the runup to filing for approval of migraine drug eptinezumab.
The Hindu Business Line  Mar 20  Comment 
The Biotechnology Industry Research Assistance Council (BIRAC) under the Department of Biotechnology celebrated its sixth foundation day here today with the launching of a partnership with Perkin


Related Articles


Biotechnology is the use of molecular biology and genetic engineering techniques to develop treatments for human diseases. Many leading companies from the industry originated in the late 70's from university research laboratories. In the 1980s after attracting venture investors and after listed in the US stock exchange,have then developed into a growing industry that uses research innovations to develop new agricultural products, biomedical tools, and human therapies such as monoclonal antibody for cancer. In 2006, 92% of employees in the biotechnology industry worked in companies that specialized in developing new drugs or medical devices and equipment, while 8% were employed in companies that specialized in agricultural products. [1] The large cap company in the group is Amgen, Genentech, Biogen-Idec, Genzyme. iShares Nasdaq Biotechnology (IBB) offers a low risk/reward investment vehicle for long term investors

Industry Information

Major Biotechnology Companies

ISTA Pharmaceuticals (ISTA)

Biotechnology Industry Trends & Forces

High Pipeline Risk for New Drugs

Dependence on Health Insurance/Medicare Coverage

Dependence on Governmental Regulations

High Volatility and Instability at Start-up

Litigation Risk

Market Share


  1. State Bioscience Initiatives 2008 Report, published by the Biotechnology Industry Organization

Top Ten/Twenty Best Selling Drugs 2009

M&A Biotechnology

Monoclonal Antibody Market 2009

Vaccine Market 2009

Global Monoclonal Antibodies Market Review 2008 (World Top Ten mAbs)

M&A Review: Pharmaceutical & Biotechnology Industry

Global Vaccine Market Review 2008 (World Top Ten Vaccines)

Ipilimumab (BMS) Review: A Cancer Breakthrough?

Denosumab (Prolia, Amgen) FDA Review & Approval

Companies in the Biotechnology Industry (193)

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki